Calumet (CLMT) Director Stephen P. Mawer Receives RSU Award

What Happened

• Stephen P. Mawer, a director of Calumet, Inc. (CLMT), received two equity awards on August 20, 2026 totaling 920 restricted stock units (RSUs): 690 RSUs and 230 RSUs. Both awards are recorded at $0.00 per share (derivative/RSU grants), so no cash changed hands on grant.
• These awards are derivatives (RSUs) that represent the economic equivalent of one share each and will be settled into common stock according to the plan and any vesting terms disclosed below.

Key Details

• Transaction date: 2026-08-20; Form 4 filed: 2026-08-21.
• Awards: 690 RSUs @ $0.00 and 230 RSUs @ $0.00 (total 920 RSUs).
• Grant value shown: $0 per unit on the filing (typical for RSU grants; economic value realized upon settlement).
• Shares owned after transaction: not specified in the provided excerpt of the filing.
• Footnotes from the filing:
  • F1: Each RSU equals the economic equivalent of one share of Calumet common stock.
  • F2: One set of RSUs will settle upon a specified date or upon termination and are 100% vested.
  • F3: Another set of RSUs will settle under the Deferred Compensation Plan and vest 25% on July 1 of each year beginning July 1, 2027.
• Filing appears timely (transaction reported the next day).

Context

• RSU grants are awards, not open-market purchases or sales; they do not by themselves indicate buying or selling sentiment until/if the shares are sold after settlement.
• The filing distinguishes between fully vested RSUs (may be settled sooner) and time-vesting RSUs under the Deferred Compensation Plan (25% annual vesting starting 2027).